
He Huang
Articles
Nuclear GTPSCS functions as a lactyl-CoA synthetase to promote histone lactylation and gliomagenesis
Dec 5, 2024 |
cell.com | Ruilong Liu |Xuelian Ren |Yae Eun Park |Huixu Feng |Xinlei Sheng |Xiaohan Song | +12 more
1State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China 2Ben May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA 3Comprehensive Cancer Center, The University of Chicago, Chicago, IL 60637, USA 4School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China 5Biological Science Division,...
-
Nov 7, 2024 |
nature.com | Jian Yu |He Huang |Erlie Jiang |Xi Zhang
AbstractAllogeneic hematopoietic stem cell transplantation (allo-HSCT) utilizing mismatched unrelated donors (MMUD) present a vital option for patients with hematologic malignancies without human leukocyte antigen (HLA)-matched donors. This multicenter retrospective study encompassed 211 adults with hematological malignancies receiving allo-HSCT with antithymocyte globulin (ATG) from ≥1 HLA locus MMUD.
-
Oct 31, 2024 |
mdpi.com | Peng Yang |He Huang |Cong Liu |Chao Yao
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Sep 24, 2024 |
nature.com | Lan-Ping Xu |De-Pei Wu |He Huang |Dai-Hong Liu |Xi Zhang |Xiao-Yu Zhu | +4 more
AbstractOver past two years, a total of 39,918 hematopoietic stem cell transplantation (HSCT) cases were reported, with 18,194 and 21,714 transplants performed in 2022 and 2023, respectively. Autologous HSCT accounted for 6562 cases (31%) in 2022, while allogeneic HSCT comprised 12,632 cases (69%). In 2023, the number of allogeneic HSCTs exceeded 15,000, maintaining a 69% share.
-
Sep 19, 2024 |
pubs.rsc.org | Katam Srinivas |Zhou Chen |Anran Chen |He Huang
Dual Single-Atom Sites Coupled with Graphene-Encapsulated Core-Shell Fe-Cu Nanoalloy for Boosting Oxygen Reduction Reaction Replacing platinum-based electrocatalysts with iron single-atom catalysts (Fe-N4-C) for the oxygen reduction reaction (ORR) remains challenging due to the symmetric electronic structure of atomically dispersed Fe-N4 sites and sluggish kinetics.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →